Pathways of fetal programming of coronary dysfunction
冠状动脉功能障碍的胎儿编程途径
基本信息
- 批准号:7942283
- 负责人:
- 金额:$ 0.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2010-09-30
- 项目状态:已结题
- 来源:
- 关键词:Adrenal Cortex HormonesAgonistArachidonic AcidsBasic ScienceBlood VesselsCardiovascular DiseasesCardiovascular PhysiologyCoronaryCoronary ArteriosclerosisCoronary arteryDataDevelopmentDexamethasoneDinoprostoneDiseaseDown-RegulationEndothelial CellsEndotheliumEnvironmentEvaluationEvolutionExposure toFellowshipFosteringFoundationsFunctional disorderGlucocorticoidsHydrogen PeroxideHypertensionInflammationLifeLow Birth Weight InfantMediatingMedicineMentorsMetabolismMicrocirculatory BedModelingMorbidity - disease rateMuscle TonusNeonatologyPathogenesisPathway interactionsPerinatal ExposurePhysiologyPlayPregnancyPrincipal InvestigatorProductionProstaglandin ProductionProstaglandin-Endoperoxide SynthaseProstaglandinsReactive Oxygen SpeciesRegulationResearchResearch PersonnelResistanceRisk FactorsRoleSignal TransductionSmooth MuscleSplanchnic CirculationSteroidsStrokeTestingTrainingTraining ProgramsVasodilator AgentsVasomotorWestern Worldarteriolecareerfetalfetal programmingiliuminterestmetabolomicsmortalityoffspringpediatricianpostnatalprogramsresponseskillsvasoconstriction
项目摘要
DESCRIPTION (provided by applicant): This proposal details a 5 year training program to develop the skills necessary to pursue independent research in basic science. The principal investigator, a board-certified Pediatrician completing the third year of fellowship training in Neonatology, is currently applying for an elective year of fellowship training to lay as strong a foundation as possible for a successful career in academic medicine. This training program centers upon studies of altered ovine coronary artery physiology following antenatal corticosteroid exposure. The global hypothesis is that dexamethasone-induced downregulation of coronary artery cyclooxygenase (COX)-depenendent prostaglandin and reactive oxygen species (ROS) production is an important aspect of fetal programming, resulting in heightened coronary artery tone. Such alterations in coronary artery reactivity could provide a mechanistic explaination for the observed associations between an adverse intrauterine environment, low birth weight and subsequent coronary artery disease. Dr. Jeffrey Segar will mentor the Pi's training with Dr. Fred Lamb acting as co-sponsor. They are well established investigators in ovine cardiovascular physiology, and their mutual interest in the study of coronary artery dysfunction 'fosters an intellectually stimulating collaborative environment that has already propelled others into successful research careers. Dr. Roghair's preliminary data demonstrating steroid-induced alterations in COX-mediated vascular reactivty in association with deceased basal ROS production has led to the evolution of the following specific aims: 1) define the role of prostaglandins in the fetal programming of coronary artery dysfunction; 2) test the hypothesis that early gestation dexamethasone exposure alters arachidonic acid-induced reactive oxygen species production; and 3) determine whether the observed alterations in conduit coronary artery reactivity are seen in physiologically-relevant resistance coronary arterioles.
描述(由申请人提供):这份建议书详细说明了一项为期5年的培训计划,以发展在基础科学领域进行独立研究所需的技能。首席研究员是一名获得董事会认证的儿科医生,完成了新生儿科学第三年的奖学金培训,目前正在申请一年的选择性奖学金培训,以尽可能为在学术医学领域的成功职业生涯奠定坚实的基础。这项培训计划的中心是研究产前接触皮质类固醇后绵羊冠状动脉生理学的变化。全球假说是,地塞米松诱导的冠状动脉环氧合酶(COX)依赖性前列腺素和活性氧(ROS)的产生下调是胎儿程序化的一个重要方面,导致冠状动脉张力升高。冠状动脉反应性的这种改变可以为观察到的不良宫内环境、低出生体重和随后的冠状动脉疾病之间的联系提供一个机制上的解释。杰弗里·西格博士将指导PI的培训,弗雷德·兰姆博士是共同发起人。他们是绵羊心血管生理学方面的知名研究人员,他们对冠状动脉功能障碍研究的共同兴趣培养了一个智力刺激的合作环境,已经推动其他人进入成功的研究生涯。Rogair博士的初步数据表明,类固醇诱导的COX介导的血管反应性改变与死亡的基础ROS产生相关,导致了以下特定目标的演变:1)确定前列腺素在胎儿冠状动脉功能障碍的编程中的作用;2)检验怀孕早期接触地塞米松改变花生四烯酸诱导的活性氧产生的假说;以及3)确定所观察到的管状冠状动脉反应性改变是否出现在生理相关的阻力冠状动脉小动脉中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT D ROGHAIR其他文献
ROBERT D ROGHAIR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT D ROGHAIR', 18)}}的其他基金
Iowa Medical Student Summer Research Program in trans-NIDDK Research
爱荷华州医学生跨 NIDDK 研究夏季研究项目
- 批准号:
10629026 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
Neonatal Growth and the Neurodevelopmental Origins of Hypertension
新生儿生长和高血压的神经发育起源
- 批准号:
7991651 - 财政年份:2010
- 资助金额:
$ 0.69万 - 项目类别:
Neonatal Growth and the Neurodevelopmental Origins of Hypertension
新生儿生长和高血压的神经发育起源
- 批准号:
8466361 - 财政年份:2010
- 资助金额:
$ 0.69万 - 项目类别:
Neonatal Growth and the Neurodevelopmental Origins of Hypertension
新生儿生长和高血压的神经发育起源
- 批准号:
8669803 - 财政年份:2010
- 资助金额:
$ 0.69万 - 项目类别:
Neonatal Growth and the Neurodevelopmental Origins of Hypertension
新生儿生长和高血压的神经发育起源
- 批准号:
8116613 - 财政年份:2010
- 资助金额:
$ 0.69万 - 项目类别:
Neonatal Growth and the Neurodevelopmental Origins of Hypertension
新生儿生长和高血压的神经发育起源
- 批准号:
8274730 - 财政年份:2010
- 资助金额:
$ 0.69万 - 项目类别:
Pathways of fetal programming of coronary dysfunction
冠状动脉功能障碍的胎儿编程途径
- 批准号:
7863931 - 财政年份:2009
- 资助金额:
$ 0.69万 - 项目类别:
Pathways of fetal programming of coronary dysfunction
冠状动脉功能障碍的胎儿编程途径
- 批准号:
7676184 - 财政年份:2006
- 资助金额:
$ 0.69万 - 项目类别:
Pathways of fetal programming of coronary dysfunction
冠状动脉功能障碍的胎儿编程途径
- 批准号:
7099218 - 财政年份:2006
- 资助金额:
$ 0.69万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 0.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 0.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 0.69万 - 项目类别: